CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,962,431 | +67.1% | 1,560,164 | +85.0% | 2.90% | +60.9% |
Q2 2023 | $27,506,097 | +120.9% | 843,228 | +138.3% | 1.80% | +126.4% |
Q1 2023 | $12,450,081 | -55.4% | 353,796 | -41.9% | 0.80% | -51.9% |
Q4 2022 | $27,901,173 | +79.6% | 608,930 | +89.9% | 1.66% | +83.2% |
Q3 2022 | $15,539,000 | +23.3% | 320,722 | -0.0% | 0.90% | -13.9% |
Q2 2022 | $12,603,000 | +443.9% | 320,780 | +409.6% | 1.05% | +496.6% |
Q1 2022 | $2,317,000 | -89.1% | 62,944 | -86.4% | 0.18% | -85.8% |
Q4 2021 | $21,166,000 | +38.8% | 464,366 | +8.8% | 1.24% | +36.9% |
Q3 2021 | $15,248,000 | +60.1% | 426,632 | -11.4% | 0.90% | +64.5% |
Q2 2021 | $9,525,000 | +5.1% | 481,323 | +23.5% | 0.55% | +0.7% |
Q1 2021 | $9,065,000 | -14.2% | 389,720 | -23.3% | 0.54% | -13.4% |
Q4 2020 | $10,564,000 | +39.7% | 508,394 | +45.5% | 0.63% | +12.1% |
Q3 2020 | $7,562,000 | +100.3% | 349,296 | +118.0% | 0.56% | +135.7% |
Q2 2020 | $3,776,000 | +57.3% | 160,217 | -24.1% | 0.24% | +9.7% |
Q3 2019 | $2,401,000 | – | 210,992 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |